106 related articles for article (PubMed ID: 2479397)
21. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
[TBL] [Abstract][Full Text] [Related]
22. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
[TBL] [Abstract][Full Text] [Related]
23. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
24. Immunoregulatory cytokine production by tumor-bearing rat spleen cells and its modulation by bleomycin.
Micallef M
Anticancer Drugs; 1993 Apr; 4(2):213-22. PubMed ID: 7683934
[TBL] [Abstract][Full Text] [Related]
25. [Influence of radiation doses in local radiotherapy on anti-tumor immunity and tumor metastasis].
Mizukoshi T
Hokkaido Igaku Zasshi; 1988 Nov; 63(6):875-81. PubMed ID: 3248769
[TBL] [Abstract][Full Text] [Related]
26. Differences of host immune response and of sensitivity to chemotherapeutic agents between two clones of rat fibrosarcoma with different metastatic potential.
Futami H; Saijo N; Sasaki Y; Sakurai M; Nomori H; Takahashi H; Ishihara J; Hoshi A; Koyama K; Hamburger AW
Jpn J Cancer Res; 1986 May; 77(5):480-6. PubMed ID: 3089979
[TBL] [Abstract][Full Text] [Related]
27. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
Gomi K; Morimoto M; Nomoto K
Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
[TBL] [Abstract][Full Text] [Related]
28. [Correlation between intracellular cyclic AMP level and cytotoxic sensitivity to anti-tumor-associated antigen antibody in rat fibrosarcoma cells].
Saito T
Hokkaido Igaku Zasshi; 1988 Nov; 63(6):882-8. PubMed ID: 2854817
[TBL] [Abstract][Full Text] [Related]
29. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
Masuda E; Maeda H
Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
[TBL] [Abstract][Full Text] [Related]
30. The therapeutic effect of the antileukemia drug busulfan as an immunomodulator on transplanted fibrosarcoma KMT-17 in WKA rats.
Mizushima Y; Koga Y; Yuhki N; Kobayashi H
Gan; 1983 Feb; 74(1):162-8. PubMed ID: 6840435
[TBL] [Abstract][Full Text] [Related]
31. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
Nagarkatti M; Kaplan AM
J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
Tomazic VJ; Farha M; Loftus A; Elias EG
J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
[TBL] [Abstract][Full Text] [Related]
33. [New direction in immunochemotherapy of cancer].
Nitta K
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1117-28. PubMed ID: 6191674
[TBL] [Abstract][Full Text] [Related]
34. Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice.
Mitani M; Mori K; Himeno K; Nomoto K
J Immunol; 1989 Mar; 142(6):2148-54. PubMed ID: 2493508
[TBL] [Abstract][Full Text] [Related]
35. Study of destructive mechanisms of the immune response to sarcoma I allograft in mice.
Vidrnová M; Nouza K; Nĕmec M
Neoplasma; 1984; 31(4):369-80. PubMed ID: 6472512
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of tolerance induction of tumor-specific delayed-type hypersensitivity responses by intravenous inoculation of tumor cells.
Sato S; Fukuzawa M; Nakajima H; Ogata M; Kosugi A; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1985 Nov; 76(11):1099-106. PubMed ID: 2935516
[TBL] [Abstract][Full Text] [Related]
37. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
[TBL] [Abstract][Full Text] [Related]
38. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
Sodhi A; Tandon P; Sarna S
Arch Geschwulstforsch; 1985; 55(1):47-61. PubMed ID: 3872651
[TBL] [Abstract][Full Text] [Related]
39. Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice.
Tanida S; Uchida H; Taniguchi K; Nomoto K
Cancer Res; 1989 Jan; 49(2):284-8. PubMed ID: 2783379
[TBL] [Abstract][Full Text] [Related]
40. Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.
Mokyr MB; Hengst JC; Dray S
Cancer Res; 1982 Mar; 42(3):974-9. PubMed ID: 6977410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
